Skip to content
Rajnish Wellness logo

Rajnish Wellness

541601 BSE
Price unavailable

Rajnish Wellness (RAJNISH) share price was ₹0.35 at the 28 Oct 2026 close; market capitalisation ₹35.49 Cr; sector Healthcare. The share price fell 57.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 580.0% year on year to ₹31.01 Cr and net profit was ₹0.12 Cr, against ₹0.22 Cr a year earlier (compared with Jun 2025). Promoters held 9.16% of Rajnish Wellness in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 48/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹0.35 −0.48 −57.83% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹35.49 Cr
EBITDA
−₹8.40 Cr
Return on Equity
-6.13%
Debt to Equity
0
Book Value
₹1.01
EPS (TTM)
−₹0.06
52W High
₹0.90
52W Low
₹0.32

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,768.2035.084,24,250 Cr5.080.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,670.0087.772,56,708 Cr15.320.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,609.0072.351,75,312 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,187.60108.081,18,199 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.0026.281,17,805 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,339.0034.681,11,764 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,364.9032.701,10,265 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Rajnish Wellness (this company)
——35 Cr0.350.00%-6.13%-7.99%169 Cr-5 Cr
Median 8 companies₹1,768.2035.081,18,002 Cr4.720.47%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

48 Average
Overall score

Data confidence 88/100

Category scores

Quality Poor 31
Returns, margins, earnings quality 22% weight
Valuation Weak 45
Cheap vs sector & own history 24% weight
Growth Strong 99
Sales & profit trajectory 9% weight
Financial Health Strong 75
Solvency, leverage, coverage 9% weight
Momentum Poor 17
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is almost debt free.
  • Stock is trading at 0.36 times its book value
  • Debtor days have improved from 137 to 49.7 days.

Weaknesses

4
  • Company has low interest coverage ratio.
  • Promoter holding is low: 9.16%
  • Company has a low return on equity of -1.95% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.08%

Technical Indicators

Oscillators

Bearish

Bearish
3
Neutral
6
Bullish
0

Overall

Bearish

Bearish
13
Neutral
6
Bullish
0

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
190% higher than 3Y

change over 1 year

Net Income Growth
—

Cash Flow Change
-104%

change over 1 year

EBITDA Margin Change
-644%

change over 1 year Operating margin 0.16% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
8.51
18.51
21.62
26.98
16.3
17.42
9.06
5.77
4.56
12
23.24
102
31.01
Expenses
8.48
18.47
21.33
26.44
16.29
16.94
8.92
6.38
4.39
12.22
24.61
109
30.96
Operating Profit
0.03
0.04
0.29
0.54
0.01
0.48
0.14
-0.61
0.17
-0.22
-1.37
-6.84
0.05
OPM %
0.35%
0.22%
1.34%
2%
0.06%
2.76%
1.55%
-10.57%
3.73%
-1.83%
-5.9%
-6.71%
0.16%
Other Income
0.83
0.23
0
0
0.35
0
0.01
0.16
0.12
0.31
0.37
0.02
0.08
Interest
0.13
0.14
0.12
0.11
0.13
0.1
0.04
0
0
0
0
0
0
Depreciation
0
0
0
0.01
0
0.01
0.01
0.01
0
0
0.01
0.01
0.01
PBT
0.73
0.13
0.17
0.42
0.23
0.37
0.1
-0.46
0.29
0.09
-1.01
-6.83
0.12
Tax %
24.66%
23.08%
35.29%
30.95%
26.09%
24.32%
20%
0%
27.59%
22.22%
-9.9%
-31.19%
0%
Net Profit
0.55
0.1
0.1
0.28
0.17
0.28
0.07
-0.46
0.22
0.06
-0.91
-4.7
0.12
EPS (₹)
0
0
0
0
0
0
0
0
0
0
-0.01
-0.05
0
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
25
28
42
14
13
26
26
77
49
142
168
Expenses
24
24
35
14
17
27
27
75
49
151
177
Operating Profit
1
3
7
0
-3
0
-1
2
0
-9
-8
OPM %
4.7%
12%
16%
1%
-24%
-0.7%
-4.3%
2.6%
0%
-6%
-5%
Other Income
0
1
0
0
4
1
2
0
1
1
1
Interest
0
1
1
1
0
0
0
1
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
PBT
1
4
6
-1
0
0
1
1
0
-8
-8
Tax %
33%
33%
28%
-2%
18%
15%
27%
29%
25%
-25%
—
Net Profit
1
2
4
-1
0
0
0
1
0
-6
-5
EPS (₹)
0.94
0.06
0.08
-0.01
0
0.01
0
0.01
0
-0.06
-0.06
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.05
3
5
5
5
11
77
77
77
102
Reserves
1
3
18
17
17
12
6
7
7
1
Borrowings
3
4
5
8
0
0
10
5
0
0
Other Liabilities
5
8
5
4
13
13
6
17
7
6
Total Liabilities
8
18
32
33
35
35
99
106
91
109
Fixed Assets
0
0
0
0
0
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
3
8
Other Assets
8
18
32
33
35
35
99
106
88
101
Total Assets
8
18
32
33
35
35
99
106
91
109
Figures in ₹ Crores

Cash Flow

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-2
-3
-9
-7
0
0
-62
2
-4
-9
Investing
0
0
0
0
0
0
0
0
9
-7
Financing
1
3
10
5
0
1
62
-2
-5
25
Net Cash Flow
0
0
1
-1
0
1
-1
0
0
9
Free Cash Flow
-2
-3
-9
-7
0
0
-62
2
-4
-9
CFO/OP
-136
-90
-118
-4,650
-4
-32
5,577
105
-41,900
94
Figures in ₹ Crores

Ratios

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
59
182
164
318
460
224
287
160
201
50
Inventory Days
152
75
77
48
27
32
59
48
79
35
Days Payable
121
145
27
56
50
17
55
78
31
7
Cash Conversion Cycle
90
111
214
310
436
238
290
130
249
77
Working Capital Days
30
102
183
702
791
407
449
305
530
182
ROCE %
—
65%
37%
1%
2%
3%
1%
2%
1%
-9%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Rajnish Wellness insights

58 extracted metrics + investor summaries across FY16–FY27.

Shareholding Pattern

FIIs0.43%Public85.18%Others5.23%Promot.9.16%As ofSep 2026

Documents

Frequently Asked Questions about Rajnish Wellness

What does Rajnish Wellness Ltd do?
Incorporated in 2015, Rajnish Wellness Ltd manufactures and sells various ayurvedic medicinal products.[1]
Where is Rajnish Wellness Ltd (RAJNISH) listed?
Rajnish Wellness Ltd trades under code 541601 on the BSE.
Which sector does Rajnish Wellness Ltd belong to?
Rajnish Wellness Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Rajnish Wellness Ltd?
Rajnish Wellness Ltd has a market capitalisation of ₹35.49 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Rajnish Wellness Ltd?
Over the last 52 weeks Rajnish Wellness Ltd has traded between ₹0.32 and ₹0.9 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Rajnish Wellness Ltd?
Rajnish Wellness Ltd reported a return on equity of -6.13%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 2015, Rajnish Wellness Ltd manufactures and sells various ayurvedic medicinal products.[1]

Website rajnishwellness.com
CEO Mr. Rajnishkumar Surendra Prasad Singh
Employees 17
Listed 2018-07-09
Face Value ₹ 1
Shares Outstanding 1,01,38,88,889

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/541601.md for Rajnish Wellness Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month